Pennsylvania State University

Neuroscience

Toxic protein 'variant' may be the next target for ALS therapies

Scientists have long known that proteins can form harmful clusters in neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). But a new study by Penn State researchers ...

Genetics

Does herpes simplex virus change during transmission?

A new study helps explain how the virus that causes herpes might change during transmission between partners and over time during a long-term infection within a human host, which could have implications for future treatment ...

Genetics

Bioprinting for bone repair improved with gene therapy

Given enough time and energy, the body will heal, but when doctors or engineers intervene, the processes do not always proceed as planned because chemicals that control and facilitate the healing process are missing. Now, ...

Medications

Repurposing FDA-approved drugs may help combat COVID-19

Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...

page 7 from 40